HIGHBuilt-in & outside partyProduct / Revenue mix
ASSURE WCD
“10-K Item 1A: 'We are therefore highly dependent on our ASSURE WCD for our continued success. ... will continue to account for nearly all of our revenue for the foreseeable future.'”
KMTS · Concentration risk · 10-K extracted
Kestra Medical Technologies, Lt (KMTS) concentration risks
Updated
The most significant concentration Kestra Medical Technologies, Lt discloses is ASSURE WCD, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Kestra Medical Technologies, Lt’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 1 disclosed concentration
HIGH1
MEDIUM0
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-09-06Kestra Medical Technologies' concentration risk is as narrow as it gets: the company is highly dependent on its ASSURE wearable cardioverter defibrillator (WCD) for its continued success, and that single product is expected to continue to account for nearly all of its revenue for the foreseeable future. This is a high-share exposure with a mixed character — it is simultaneously Kestra's core value driver and its single largest point of failure, since there is no disclosed second product line to fall back on if ASSURE WCD demand weakens, faces reimbursement pressure, or encounters a competitive or regulatory setback. Because virtually the entire business rests on one device, any shock specific to that product — whether clinical, regulatory, or competitive — would flow through to nearly all of the company's revenue rather than being cushioned by other segments. Investors should treat ASSURE WCD's trajectory as effectively synonymous with the company's overall trajectory until further product diversification is disclosed.
For the engine’s reasoning on KMTS’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Instruments & Supplies
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ANGO | AngioDynamics, Inc. | 2 | 0 | 0 | 2 |
| ATRC | AtriCure, Inc. | 1 | 1 | 1 | 3 |
| ATR | AptarGroup, Inc. | 1 | 1 | 0 | 2 |
| ALGN | Align Technology, Inc. | 1 | 0 | 0 | 1 |
| AVTR | Avantor, Inc. | 1 | 0 | 0 | 1 |
| KMTS● | Kestra Medical Technologies, Lt | 1 | 0 | 0 | 1 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.